Strategic partnership IntegraGen is part of the OncoDNA group, leveraging a broader network to expand market reach and co-develop solutions. Sales opportunities exist in cross-selling services, joint offerings, and access to a wider distributor network.

NGS leadership Operates one of the largest next-generation sequencing labs in France with emphasis on cancer and rare genetic diseases. Target hospitals, research institutes, and biopharma partners investing in genomic profiling and biomarker discovery.

Clinical tools Existing MERCURY and SIRIUS SaaS tools enable large-scale genomic data analysis and clinical interpretation. Upsell to labs needing cloud-based analytics, data management, and diagnostic support for precision medicine programs.

Global reach Presence in the United States and a global network of 35 distributors through the OncoDNA group. Explore international pilots, regional collaborations, and distributor-led campaigns to accelerate adoption.

Growth potential Revenue in the low-to-mid millions with a focused team. Opportunity to scale through renewed licensing deals, expanded biomarker testing, and enhanced services for late-stage solid tumors and rare diseases, appealing to pharma and academic partners.